Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 95

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 95
---
 business, such as claims brought by its clients or vendors in connection with commercial disputes
or employment claims made by its current or former employees, as well as claims brought by relevant regulatory authorities or NewGenIvf’s
competitors, patients, employees, or other third parties against NewGenIvf. NewGenIvf is unable to predict the outcome of any of these
legal proceedings. Such regulatory actions, disputes, allegations, complaints, or legal proceedings may damage NewGenIvf’s reputation,
evolve into litigation, or otherwise have a material adverse impact on NewGenIvf’s reputation and business. Such proceedings might
result in substantial costs, regardless of the outcome, and may significantly divert management’s attention and resources from
operating NewGenIvf’s business, which might seriously harm its business, financial condition and results of operations. Insurance
might not cover such claims, might not provide sufficient payments to cover all the costs to resolve one or more such claims, and might
not continue to be available on terms acceptable to it. A claim brought against it that is uninsured or underinsured could result in
unanticipated costs, potentially harming its business, financial condition and results of operations. The outcomes of actions NewGenIvf
institutes may not be successful or favorable to NewGenIvf. Lawsuits against NewGenIvf may also generate negative publicity that significantly
harms NewGenIvf’s reputation, which may adversely affect NewGenIvf’s client base. NewGenIvf may also need to pay damages
or settle lawsuits with a substantial amount of cash.

<div align='center'>51</div>

Acquisitions, strategic investments, partnerships, or alliances could be difficult to identify, pose integration challenges, divert the attention of management, disrupt NewGenIvf’s business, dilute stockholder value, and adversely affect its business, financial condition and results of operations.

NewGenIvf may in the future
seek to acquire or invest in businesses, joint ventures, products and services, or technologies that it believes could complement or
expand its platform, enhance its technical capabilities, or otherwise offer growth opportunities. Any such acquisition or investment
may divert the attention of management and cause NewGenIvf to incur various expenses in identifying, investigating and pursuing suitable
opportunities, whether or not the transactions are completed, and may result in unforeseen operating difficulties and expenditures. In
particular, NewGenIvf may encounter difficulties assimilating or integrating the businesses, technologies, products and services